Jorge Delgado, Principal Medical Science Liaison at Daiichi Sankyo US, shared a post on LinkedIn:
“Grateful for the opportunity to participate in our DATROWAY launch meeting and represent Medical Affairs as part of the insights panel.
It was a great experience partnering with our marketing, market access, commercial, and cross-functional colleagues as we helped prepare teams for the launch of DATROWAY in triple-negative breast cancer.
Over the course of a few days, I had the chance to learn from colleagues across the organization, contribute Medical Affairs perspective, and help support the thoughtful exchange of insights that will be important as our field teams engage with healthcare providers.
I’m thankful for the collaboration, partnership, and energy across the team. Excited for what’s ahead and proud to be part of this important work.”
Other articles featuring DATROWAY on OncoDaily.